-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 4, Fangsheng Pharmaceutical announced that due to personal reasons, Zhang Qinghua, the company's chairman and general manager, applied to resign from his positions as the company's chairman (legal representative), director, director of the strategic development committee of the board of directors and general manager
.
After his resignation, Mr.
Zhang Qinghua will still hold other positions in the company
.
According to the author's incomplete statistics, as of January 1, 2022, in addition to Fangsheng Pharmaceutical, at least 5 pharmaceutical companies have announced the resignation of the company's chairman, including Jinhua, Harbin Pharmaceutical, Zhengye Biology, China Resources Pharmaceutical, Dong'er Ejiao, etc.
, and the reasons for leaving mainly include job changes, retirement, personal reasons,
etc.
For example, on February 22, Jinhua Co.
, Ltd.
announced that the company's board of directors received a written resignation from the company's chairman, Mr.
Zhang Chaoyang, on February 21, 2022.
Due to work needs, Mr.
Zhang Chaoyang applied to resign as the company's chairman.
, and continued to serve as a director of the company after his resignation
.
In addition, Mr.
Xing Yajiang was elected as the chairman of the ninth session of the board of directors of the company, and the term of office starts from the date of deliberation and approval by the company's board of directors to the date when the term of the ninth session of the board of directors expires
.
Mr.
Zhang Chaoyang was elected as the vice chairman of the ninth board of directors of the company
.
On February 12, Harbin Pharmaceutical Co.
, Ltd.
issued an announcement stating that due to retirement reasons, Mr.
Zhang Zhenping resigned from the company's vice chairman, director, and member of the Remuneration and Assessment Committee.
After resigning, he did not hold any other positions in the company.
Effective from the date of the Board of Directors
.
On February 8, Zhengye Bio announced that Ms.
Shao Yu voluntarily resigned from the company's director and chairman positions due to personal reasons, and will no longer hold other positions in the company after her resignation
.
On January 28, China Resources Pharma issued an announcement on changes in the chairman, general manager and directors, saying that Han Yuewei would no longer serve as its director, chairman and legal representative, and Zhao Bingxiang would no longer serve as a director; Bai Xiaosong was appointed as director and chairman at the same time.
and legal representative, appointed Tao Ran as director
.
On January 10, Dong'e Ejiao issued the "Announcement on the Resignation of the Chairman", announcing that Han Yuewei had applied to resign from the positions of chairman, director and chairman of the strategy committee of the tenth board of directors due to job changes
.
On the same day, Dong’e Ejiao also announced that Gao Dengfeng had applied to resign as president and legal representative of Dong’e Ejiao due to changes in his work content
.
In addition, Dong E E Jiao announced in the newly released "Announcement on Resolutions of the Fifth Meeting of the Tenth Board of Directors" that Gao Dengfeng will serve as the chairman of the tenth board of directors, and Cheng Jie will be its president
.
In addition to the announcement of the resignation of the above-mentioned chairman of the pharmaceutical company, some pharmaceutical companies have announced that the company has ushered in a new chairman since the beginning of this year
.
For example, on February 14, Hangzhou Tianmushan Pharmaceutical issued an announcement on the election of the chairman, vice chairman and adjustment of the special committee and the change of the legal representative
.
The announcement stated that director Li Feng was elected as the chairman of the 11th board of directors of the company, and director Liu Bo was elected as the vice chairman of the 11th board of directors of the company.
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
After his resignation, Mr.
Zhang Qinghua will still hold other positions in the company
.
According to the author's incomplete statistics, as of January 1, 2022, in addition to Fangsheng Pharmaceutical, at least 5 pharmaceutical companies have announced the resignation of the company's chairman, including Jinhua, Harbin Pharmaceutical, Zhengye Biology, China Resources Pharmaceutical, Dong'er Ejiao, etc.
, and the reasons for leaving mainly include job changes, retirement, personal reasons,
etc.
For example, on February 22, Jinhua Co.
, Ltd.
announced that the company's board of directors received a written resignation from the company's chairman, Mr.
Zhang Chaoyang, on February 21, 2022.
Due to work needs, Mr.
Zhang Chaoyang applied to resign as the company's chairman.
, and continued to serve as a director of the company after his resignation
.
In addition, Mr.
Xing Yajiang was elected as the chairman of the ninth session of the board of directors of the company, and the term of office starts from the date of deliberation and approval by the company's board of directors to the date when the term of the ninth session of the board of directors expires
.
Mr.
Zhang Chaoyang was elected as the vice chairman of the ninth board of directors of the company
.
On February 12, Harbin Pharmaceutical Co.
, Ltd.
issued an announcement stating that due to retirement reasons, Mr.
Zhang Zhenping resigned from the company's vice chairman, director, and member of the Remuneration and Assessment Committee.
After resigning, he did not hold any other positions in the company.
Effective from the date of the Board of Directors
.
On February 8, Zhengye Bio announced that Ms.
Shao Yu voluntarily resigned from the company's director and chairman positions due to personal reasons, and will no longer hold other positions in the company after her resignation
.
On January 28, China Resources Pharma issued an announcement on changes in the chairman, general manager and directors, saying that Han Yuewei would no longer serve as its director, chairman and legal representative, and Zhao Bingxiang would no longer serve as a director; Bai Xiaosong was appointed as director and chairman at the same time.
and legal representative, appointed Tao Ran as director
.
On January 10, Dong'e Ejiao issued the "Announcement on the Resignation of the Chairman", announcing that Han Yuewei had applied to resign from the positions of chairman, director and chairman of the strategy committee of the tenth board of directors due to job changes
.
On the same day, Dong’e Ejiao also announced that Gao Dengfeng had applied to resign as president and legal representative of Dong’e Ejiao due to changes in his work content
.
In addition, Dong E E Jiao announced in the newly released "Announcement on Resolutions of the Fifth Meeting of the Tenth Board of Directors" that Gao Dengfeng will serve as the chairman of the tenth board of directors, and Cheng Jie will be its president
.
In addition to the announcement of the resignation of the above-mentioned chairman of the pharmaceutical company, some pharmaceutical companies have announced that the company has ushered in a new chairman since the beginning of this year
.
For example, on February 14, Hangzhou Tianmushan Pharmaceutical issued an announcement on the election of the chairman, vice chairman and adjustment of the special committee and the change of the legal representative
.
The announcement stated that director Li Feng was elected as the chairman of the 11th board of directors of the company, and director Liu Bo was elected as the vice chairman of the 11th board of directors of the company.
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
